Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. May 14, 2020; 26(18): 2138-2154
Published online May 14, 2020. doi: 10.3748/wjg.v26.i18.2138
Figure 1
Figure 1 Proposal of a treatment algorithm for diabetes mellitus type II in liver transplant recipients. GLP-1 RA: Glucagon-like peptide-1 receptor agonist; SGLT2 inhibitors: Sodium-glucose cotransporter type 2; DPP-4l: Inhibitors of dipeptidyl peptidase 4; NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease.